PCR & machine learning could detect breast cancer risk with 94% accuracy

The new study funded by top US research organisations like the National Institutes of Health, Harvard Cancer Center Ovarian Cancer SPORE, Dana Farber Cancer Institute and others reveals that mutations in the BRCA1 and BRCA2 genes associated with breast and ovarian cancer can be detected without sequencing…
Read More